📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer. (2021)

First Author: McKenzie DR

Attributed to: CARDINNATE: Variation in innate immune activation and cardiovascular disease risk as drivers of COVID19 outcome in South Asians in UK and India funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2021.10.003

PubMed Identifier: 34678151

Publication URI: http://europepmc.org/abstract/MED/34678151

Type: Journal Article/Review

Volume: 39

Parent Publication: Cancer cell

Issue: 11

ISSN: 1535-6108